Incannex Healthcare Inc (NASDAQ:IXHL) currently has a daily average trading volume of 26.14M but it saw 382008834 shares traded in last market. With a market cap of 7.40M USD, the company’s current market price of $0.27 came falling about -61.64 while comparing to the previous closing price of $0.70. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.55 and as low as $0.08.
Taking a look at 20-day trading activity of Incannex Healthcare Inc (IXHL) gives us an average price of $0.3234, while its current price level is -92.44% below from 52-week high level whereas it is 235.63% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.5634 while that of 200 days or SMA-200 reads an average of $1.5510. A closer look into the stock’s movement over the week reveals that its volatility is standing at 113.41% during that period while stretching the period over a month that decreases to 35.89%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 45.65 which implies that the stock is in neutral territory.
Over the week, IXHL’s stock price is moving 138.45% up while it is -55.98% when we observe its performance for the past one month. Year-to-date it is -87.33% down and over the past year, the stock is showing a downside performance of -89.75%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0. In next quarter, company is expected to be making quarterly sales of $157k as analysts are expecting the sales for current fiscal year at $472k and seeing the company making $787k in sales next year. Moreover, analysts are in estimates of $157k for current-quarter revenue.
Currently, Incannex Healthcare Inc’s total number of outstanding shares is 27.55M with 27.93% of that held by the insiders while 8.54% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -679.78% and return on equity (ROE) at -240.02%. Stock’s beta reads 4.30. Stock has a price to book (P/B) ratio of 4.95 while price to sale or P/S ratio amounts to 73.97. Its return on asset (ROA) is -142.27% on average.
